今日の臨床サポート 今日の臨床サポート
関連論文:
img  31:  The Association of Estimated Glomerular Filtration Rate With Diabetic Retinopathy and Macular Edema.
 
著者: Ryan Eyn Kidd Man, Muhammad Bayu Sasongko, Jie Jin Wang, Richard MacIsaac, Tien Yin Wong, Charumathi Sabanayagam, Ecosse L Lamoureux
雑誌名: Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4810-6. doi: 10.1167/iovs.15-16987.
Abstract/Text PURPOSE: Albuminuria, a marker of diabetic kidney disease, is closely associated with diabetic retinopathy (DR) and diabetic macular edema (DME). However, the relationship between estimated glomerular filtration rate (eGFR) with DR and DME remains unclear, particularly in type 2 diabetes. We investigated the association of eGFR with DR and DME in a sample of patients with type 2 diabetes.
METHODS: We included 263 Caucasian patients with type 2 diabetes aged ≥ 18 years who participated in a clinic-based cross-sectional study in Melbourne, Australia. Diabetic retinopathy (n = 140) and DME (n = 61) were assessed from retinal photographs graded using the modified Airlie House classification and further confirmed with optical coherence tomography. Estimated glomerular filtration rate, assessed using the CKD-EPI formula, was analyzed continuously (per SD change) and categorically (normal renal function ≥ 90; impaired renal function, 60-89, and chronic kidney disease [CKD] < 60 mL/min/1.73 m2).
RESULTS: When eGFR was analyzed categorically, impaired renal function and CKD were associated with the presence of DR when compared to normal renal function in multivariable models (odds ratio [OR] with 95% confidence interval [CI] of 2.97 [1.12-7.87] and 3.77 [1.28-11.10]), respectively. In DR severity analyses, CKD showed significant associations with moderate (5.83 [1.44-23.5], P-trend = 0.02) and severe DR (4.91 [1.26-19.0], P-trend = 0.04). These associations persisted when eGFR was analyzed continuously (P = 0.04). No significant associations were found between eGFR and DME.
CONCLUSIONS: Our results suggest that lower levels of eGFR were associated with the presence and severity of DR, but not with DME.

PMID 26218909  Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4810-6. doi: 10.1167/iovs.15-16987.
戻る

さらなるご利用にはご登録が必要です。

こちらよりご契約または優待日間無料トライアルお申込みをお願いします。

(※トライアルご登録は1名様につき、一度となります)


ご契約の場合はご招待された方だけのご優待特典があります。

以下の優待コードを入力いただくと、

契約期間が通常12ヵ月のところ、14ヵ月ご利用いただけます。

優待コード: (利用期限:まで)

ご契約はこちらから